Toptas, T. Et Al. 2018. The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.3 , 587-592.

Toptas, T., Pestereli, E., ŞİMŞEK, T., Bozkurt, S., ERDOĞAN, G., & Karaveli, S., (2018). The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.3, 587-592.

Toptas, TAYFUN Et Al. "The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum," JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.3, 587-592, 2018

Toptas, TAYFUN Et Al. "The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum." JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.3, pp.587-592, 2018

Toptas, T. Et Al. (2018) . "The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum." JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.3, pp.587-592.

@article{article, author={TAYFUN TOPTAŞ Et Al. }, title={The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum}, journal={JOURNAL OF CANCER RESEARCH AND THERAPEUTICS}, year=2018, pages={587-592} }